Search
for
Sort by
Research 421–450 of 1000+
- Unveiling the Nuances of Adult Female Acne: A Comprehensive Exploration of Epidemiology, Treatment Modalities, Dermocosmetics, and the Menopausal Influence
- Profile of Female Hyperandrogenism at the Medical Clinic II: About 19 Cases
- Non-Contraceptive Benefits of Oral Hormonal Contraceptives
- Polycystic Ovary Syndrome and Reproductive Health: A Comprehensive Review
- Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- ZALCITABINE
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Hyperandrogenic Disorders
- The Hirsute Woman: Challenges in Evaluation and Management
- The Role of Probiotics and Synbiotics on Hirsutism
- Treatment Advances for Acne Vulgaris: The Scientific Role of Cannabinoids
- Androgens/Androgen Receptor in the Management of Skin Diseases
- Prevalence and Metabolic Characterization of Polycystic Ovary Syndrome in a Cohort of Patients Diagnosed with Spina Bifida: Study Protocol
- Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies
- Androgenetic Alopecia: An Update of Treatment Options
- Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
- Androgenetic Alopecia: Clinical Treatment
- Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3α-androstanediol and 17β-estradiol
- Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial
- Role of Oxidative Stress in Obese and Nonobese PCOS Patients
- 5α-Reduced glucocorticoids: a story of natural selection
- Expression and function of nuclear receptor co-activator 4: evidence of a potential role independent of co-activator activity
- Attenuating 5α-pregnane-3α-ol-20-one formation in the hippocampus of female rats increases pentylenetetrazole-induced seizures
- Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients
- The connection of 5-alpha reductase inhibitors to the development of depression
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- Skin Androgen-Related Disorders: Hormonal Treatment
- Hyperandrogenic Symptoms Are a Persistent Suffering in Midlife Women with PCOS; a Prospective Cohort Study in Sweden